Calcium and vitamin d supplementation in men
- PMID: 21876835
- PMCID: PMC3163142
- DOI: 10.4061/2011/875249
Calcium and vitamin d supplementation in men
Abstract
Calcium and vitamin D supplements reverse secondary hyperparathyroidism and are widely prescribed to prevent osteoporotic fractures, with proven antifracture efficacy when targeted to individuals with documented insufficiencies. Men who should particularly be considered for calcium and vitamin D supplements include elderly or institutionalized individuals, patients with documented osteoporosis on antiresorptive or anabolic medication, and individuals receiving glucocorticoids. Benefits are most apparent when a daily dose of 1000-1200 mg calcium is complemented with 800 IU vitamin D. Compliance is the key to optimizing clinical efficacy. While (conventionally dosed) vitamin D has not been associated with safety concerns, recent meta-analytic data have provided evidence to suggest that calcium supplements (without coadministered vitamin D) may potentially be associated with cardiovascular risks.
Similar articles
-
Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update.J Intern Med. 2006 Jun;259(6):539-52. doi: 10.1111/j.1365-2796.2006.01655.x. J Intern Med. 2006. PMID: 16704554 Review.
-
Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence.Calcif Tissue Int. 2006 May;78(5):257-70. doi: 10.1007/s00223-005-0009-8. Epub 2006 Apr 21. Calcif Tissue Int. 2006. PMID: 16622587 Review.
-
Who should receive calcium and vitamin D supplementation?Age Ageing. 2012 Sep;41(5):576-80. doi: 10.1093/ageing/afs094. Epub 2012 Aug 8. Age Ageing. 2012. PMID: 22877606
-
Reducing fracture risk with calcium and vitamin D.Clin Endocrinol (Oxf). 2010 Sep;73(3):277-85. doi: 10.1111/j.1365-2265.2009.03701.x. Clin Endocrinol (Oxf). 2010. PMID: 20796001 Review.
-
[Are calcium and vitamin D supplements for everyone?: Pro].Reumatol Clin. 2011 Sep;7 Suppl 2:S34-9. doi: 10.1016/j.reuma.2011.04.008. Epub 2011 Jun 24. Reumatol Clin. 2011. PMID: 21924218 Spanish.
Cited by
-
Gossypol Promotes Bone Formation in Ovariectomy-Induced Osteoporosis through Regulating Cell Apoptosis.Biomed Res Int. 2018 Dec 13;2018:3635485. doi: 10.1155/2018/3635485. eCollection 2018. Biomed Res Int. 2018. PMID: 30643801 Free PMC article.
-
Blood Cadmium Is Associated with Osteoporosis in Obese Males but Not in Non-Obese Males: The Korea National Health and Nutrition Examination Survey 2008-2011.Int J Environ Res Public Health. 2015 Sep 28;12(10):12144-57. doi: 10.3390/ijerph121012144. Int J Environ Res Public Health. 2015. PMID: 26426028 Free PMC article.
-
The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment.Nutrients. 2014 Oct 21;6(10):4491-519. doi: 10.3390/nu6104491. Nutrients. 2014. PMID: 25338271 Free PMC article. Review.
-
Interaction between bone and muscle in older persons with mobility limitations.Curr Pharm Des. 2014;20(19):3178-97. doi: 10.2174/13816128113196660690. Curr Pharm Des. 2014. PMID: 24050165 Free PMC article. Review.
-
Causes, consequences, and treatment of osteoporosis in men.Drug Des Devel Ther. 2013 Aug 22;7:849-60. doi: 10.2147/DDDT.S46101. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24009413 Free PMC article. Review.
References
-
- National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC, USA: National Osteoporosis Foundation; 2008.
-
- Heaney RP. Is the paradigm shifting? Bone. 2003;33(4):457–465. - PubMed
-
- Boonen S, Bischoff-Ferrari HA, Cooper C, et al. Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcified Tissue International. 2006;78(5):257–270. - PubMed
-
- Boonen S, Vanderschueren D, Geusens P, Bouillon R. Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men. International Journal of Andrology. 1997;20(3):134–143. - PubMed
-
- Visser M, Deeg DJH, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (Sarcopenia): the longitudinal aging study Amsterdam. Journal of Clinical Endocrinology and Metabolism. 2003;88(12):5766–5772. - PubMed
LinkOut - more resources
Full Text Sources
